An enzyme in the blue blood has been key to testing vaccines since the 1980s, raising concerns for the crabs’ population. But ...

Xencor, Inc. , a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today announced initial results from the ongoing Phase 1 ...

Gilead Sciences approaches Q3 2025 results on October 30, hitting new highs and presenting Livdelzi data at The Liver Meeting ...

The Future of Cellular Regeneration As we advance into 2026, the realm of cellular regeneration has witnessed remarkable innovations that promise to transform our understanding of health, wellness, ...

Background Lupus nephritis (LN) is the most serious complication of SLE. Interstitial fibrosis is the dominant pathological ...

Researchers have revealed a novel mechanism by which the chromatin remodeler brahma-related gene 1 (Brg1) regulates Group 2 ...

Researchers at the University of California, Irvine, have uncovered an unexpected molecular partnership that reshapes ...

They are uncomfortable, annoying and occasionally dangerous. But fevers are also an essential part of how we protect ...

It has long been known that bacterial pathogens are becoming increasingly resistant to antibiotics. However, common ...

In a new study, scientists examined how a common dietary fiber can potentially protect the liver. They mainly focused on ...

Lead antibacterial compound against a novel target in Gram-negative bacteria validated in infection modelsProgressing a ...